Annual report pursuant to Section 13 and 15(d)

3. Acquisitions (Details Narrative)

v3.7.0.1
3. Acquisitions (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Issuance of common stock in connection with completion of asset acquisition, value $ 34,902,444  
Proceeds from issuance of units in offering 8,969,998 $ 0
Asset Purchase Agreement [Member]    
Convertible debt issued $ 4,500,000  
Asset Purchase Agreement [Member] | Pharmsynthez [Member]    
Issuance of common stock in connection with completion of asset acquisition, shares 3,045,455  
Conversion of notes, shares issued 1,373,036  
Proceeds from issuance of units in offering $ 5,500,000